CitiColine to help protect the brain in preterm babies
Part of Women’s health & pregnancy clinical trials.
This Phase 3 study tests whether citicoline can act as a protective treatment for the brain in babies born early and needing breathing support. It may help reduce risks tied to prematurity and breathing complications by supporting the brain’s health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born preterm (early)
- Your baby needs breathing support using CPAP or a ventilator
- Your baby does not have multiple birth defects (multiple congenital anomalies)
- Your baby’s care team determines they can safely take part in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a medicine called citicoline can protect the brain in newborns who had low oxygen (hypoxia). It may help reduce brain injury in babies, but it does not include babies with a specific severe brain condition.
This study tests a medicine called citicoline to see if it can help babies who had a lack of oxygen around birth (which can lead to brain injury). The goal is to reduce brain damage and improve recovery.
This trial tests whether giving caffeine citrate early to very premature babies (born before 32 weeks) improves their breathing and long-term health. It aims to find the best way to use this common medicine to help your baby grow and develop.
This Phase 3 study tests ways to protect brain health in newborns who are very premature or recently born and need a breathing machine through a tube. It may help reduce the risk of brain injury while they receive intensive care.
This trial tests if giving caffeine to late preterm babies with breathing problems helps them need less breathing support. It could be an extra treatment alongside standard care.
This trial studies whether an oral medicine called L-citrulline (L-cit) is safe and how it works in very preterm infants. It includes two groups: babies with chronic lung disease (with or without high blood pressure in the lungs) and babies recovering from severe bowel infection (NEC).
Hear when a new Pre-Term trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.